Q13131
Gene name |
PRKAA1 (AMPK1) |
Protein name |
5'-AMP-activated protein kinase catalytic subunit alpha-1 |
Names |
AMPK subunit alpha-1, Acetyl-CoA carboxylase kinase, ACACA kinase, Hydroxymethylglutaryl-CoA reductase kinase, HMGCR kinase, Tau-protein kinase PRKAA1 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:5562 |
EC number |
2.7.11.1: Protein-serine/threonine kinases |
Protein Class |
MAP/MICROTUBULE AFFINITY-REGULATING KINASE (PTHR24346) |

Descriptions
AMP-activated protein kinase (AMPK) acts as an energy sensor, being activated by metabolic stresses and regulating cellular metabolism. AMPK is a heterotrimer consisting of a catalytic alpha subunit and two regulatory subunits, beta and gamma. AMPK alpha subunit contains an autoinhibitory domain that inhibits the N-terminal kinase domain. Autoinhibitory region of AMPK alpha are not only responsible for kinase autoinhibition, but may also be responsible for full-length kinase degradation.
Autoinhibitory domains (AIDs)
Target domain |
27-279 (Protein kinase domain) |
Relief mechanism |
Ligand binding |
Assay |
Deletion assay, Mutagenesis experiment |
Accessory elements
167-189 (Activation loop from InterPro)
Target domain |
27-279 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
References
- Pang T et al. (2007) "Conserved alpha-helix acts as autoinhibitory sequence in AMP-activated protein kinase alpha subunits", The Journal of biological chemistry, 282, 495-506
- Hardie DG et al. (2012) "AMP-activated protein kinase: a target for drugs both ancient and modern", Chemistry & biology, 19, 1222-36
- Li YY et al. (2013) "Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice", Toxicology and applied pharmacology, 273, 325-34
- Oakhill JS et al. (2009) "Structure and function of AMP-activated protein kinase", Acta physiologica (Oxford, England), 196, 3-14
- Pang T et al. (2008) "Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells", The Journal of biological chemistry, 283, 16051-60
- Scott JW et al. (2014) "ATP sensitive bi-quinoline activator of the AMP-activated protein kinase", Biochemical and biophysical research communications, 443, 435-40
Autoinhibited structure

Activated structure

13 structures for Q13131
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
4RED | X-ray | 295 A | A/B | 22-362 | PDB |
4RER | X-ray | 405 A | A | 20-559 | PDB |
4REW | X-ray | 458 A | A | 20-559 | PDB |
5EZV | X-ray | 299 A | A/C | 359-401 | PDB |
6C9F | X-ray | 292 A | A | 22-559 | PDB |
6C9G | X-ray | 270 A | A | 22-559 | PDB |
6C9H | X-ray | 265 A | A | 22-559 | PDB |
6C9J | X-ray | 305 A | A | 22-559 | PDB |
7JHG | EM | 347 A | A | 22-559 | PDB |
7JHH | EM | 392 A | A | 22-559 | PDB |
7JIJ | X-ray | 550 A | A | 22-559 | PDB |
7M74 | EM | 393 A | A | 22-559 | PDB |
AF-Q13131-F1 | Predicted | AlphaFoldDB |
271 variants for Q13131
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs1033125825 CA359580432 |
2 | R>C | No |
ClinGen TOPMed gnomAD |
|
CA359580433 rs1033125825 |
2 | R>G | No |
ClinGen TOPMed gnomAD |
|
COSM1068168 COSM1068167 rs1426382824 CA359580429 |
2 | R>H | endometrium [Cosmic] | No |
ClinGen cosmic curated gnomAD |
rs1426382824 CA359580426 |
2 | R>L | No |
ClinGen gnomAD |
|
rs1033125825 CA117232237 |
2 | R>S | No |
ClinGen TOPMed gnomAD |
|
rs1188565639 CA359580419 |
3 | R>K | No |
ClinGen gnomAD |
|
rs1423481695 CA359580414 |
3 | R>S | No |
ClinGen gnomAD |
|
rs1254288802 CA359580403 |
4 | L>P | No |
ClinGen gnomAD |
|
CA3248651 rs773228528 |
5 | S>R | No |
ClinGen ExAC gnomAD |
|
CA359580376 rs1286001321 |
6 | S>F | No |
ClinGen TOPMed gnomAD |
|
rs551347552 CA3248650 |
7 | W>* | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA117232218 rs939151107 |
7 | W>R | No |
ClinGen TOPMed gnomAD |
|
CA359580326 rs1244459595 |
10 | M>K | No |
ClinGen gnomAD |
|
CA117232215 VAR_058401 rs17855679 |
10 | M>L | No |
ClinGen UniProt Ensembl dbSNP |
|
rs1244459595 CA359580324 |
10 | M>T | No |
ClinGen gnomAD |
|
CA3248649 rs748031628 |
11 | A>T | No |
ClinGen ExAC gnomAD |
|
rs867953599 CA117232211 |
11 | A>V | No |
ClinGen Ensembl |
|
rs1382314545 CA359580301 |
12 | T>I | No |
ClinGen TOPMed gnomAD |
|
CA359580259 rs1469720215 |
15 | K>R | No |
ClinGen TOPMed |
|
COSM33502 rs928784854 VAR_035622 COSM1437563 CA117232187 |
16 | Q>R | a breast cancer sample; somatic mutation large_intestine breast [UniProt, Cosmic] | No |
ClinGen cosmic curated UniProt TOPMed dbSNP gnomAD |
CA3248643 rs749919427 |
18 | H>P | No |
ClinGen ExAC TOPMed gnomAD |
|
rs766987004 CA117232162 |
18 | H>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
COSM3784897 rs377040057 CA3248644 COSM3784896 |
18 | H>Y | pancreas [Cosmic] | No |
ClinGen cosmic curated ESP ExAC TOPMed gnomAD |
CA3248641 rs199741192 |
20 | G>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs753214385 CA3248640 |
22 | V>M | No |
ClinGen ExAC gnomAD |
|
CA359580138 rs759922711 |
25 | G>R | No |
ClinGen ExAC gnomAD |
|
rs759922711 CA3248638 |
25 | G>S | No |
ClinGen ExAC gnomAD |
|
rs766616413 CA3248636 |
26 | H>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3248635 rs760844250 |
27 | Y>C | No |
ClinGen ExAC gnomAD |
|
rs1209624022 CA359580098 |
28 | I>F | No |
ClinGen gnomAD |
|
CA359580100 rs1209624022 |
28 | I>V | No |
ClinGen gnomAD |
|
CA3248634 rs773317301 |
31 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1429046828 CA359580062 |
31 | D>V | No |
ClinGen gnomAD |
|
rs773317301 CA359580067 |
31 | D>Y | No |
ClinGen ExAC TOPMed gnomAD |
|
rs772007686 CA3248633 |
32 | T>M | No |
ClinGen ExAC gnomAD |
|
rs774220592 CA3248631 |
35 | V>I | No |
ClinGen ExAC gnomAD |
|
rs1331613081 CA359580012 |
36 | G>R | No |
ClinGen gnomAD |
|
rs1205168457 CA359578326 |
43 | V>A | No |
ClinGen gnomAD |
|
rs1398359834 CA359579916 |
43 | V>F | No |
ClinGen TOPMed gnomAD |
|
rs377206671 CA359578314 |
44 | G>D | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs377206671 CA3248607 |
44 | G>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs374595923 CA3248606 |
46 | H>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA117215346 rs755206740 |
48 | L>F | No |
ClinGen Ensembl |
|
CA359578239 rs1198171523 |
48 | L>W | No |
ClinGen gnomAD |
|
CA3248605 rs780649839 |
49 | T>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1176438429 CA359578193 |
50 | G>R | No |
ClinGen TOPMed |
|
CA3248602 rs777461699 |
55 | V>L | No |
ClinGen ExAC gnomAD |
|
rs930784916 CA117215266 |
59 | N>S | No |
ClinGen TOPMed |
|
CA3248600 rs754248249 |
60 | R>* | No |
ClinGen ExAC |
|
rs780617578 CA3248599 |
60 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1261017903 CA359578086 |
64 | R>Q | No |
ClinGen gnomAD |
|
rs369977975 CA3248597 |
64 | R>W | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA359578080 rs1412797330 |
65 | S>I | No |
ClinGen TOPMed gnomAD |
|
CA359578078 rs1412797330 |
65 | S>N | No |
ClinGen TOPMed gnomAD |
|
CA359578079 rs1412797330 |
65 | S>T | No |
ClinGen TOPMed gnomAD |
|
rs762063813 CA3248595 |
68 | V>M | No |
ClinGen ExAC gnomAD |
|
rs200927672 CA3248594 |
73 | R>C | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs764113006 CA3248593 |
73 | R>H | No |
ClinGen ExAC gnomAD |
|
CA359578009 rs1185114438 |
76 | I>V | No |
ClinGen gnomAD |
|
rs977171885 CA117215189 |
79 | L>F | No |
ClinGen Ensembl |
|
rs1290622927 CA359577984 |
79 | L>P | No |
ClinGen TOPMed |
|
CA117215173 rs377014464 |
84 | H>Q | No |
ClinGen ESP TOPMed gnomAD |
|
rs879036617 CA117215169 |
87 | I>M | No |
ClinGen Ensembl |
|
CA359577932 rs1228019406 |
87 | I>V | No |
ClinGen TOPMed |
|
rs769782415 CA3248590 |
89 | K>T | No |
ClinGen ExAC gnomAD |
|
rs201964697 CA117213759 |
95 | S>C | No |
ClinGen TOPMed gnomAD |
|
CA3248566 rs765077004 |
95 | S>T | No |
ClinGen ExAC gnomAD |
|
rs945243312 CA117213755 |
100 | I>N | No |
ClinGen Ensembl |
|
CA117213753 rs865932512 |
103 | V>A | No |
ClinGen gnomAD |
|
rs759557332 CA3248565 |
105 | E>* | No |
ClinGen ExAC gnomAD |
|
CA359577717 rs776543926 |
105 | E>D | No |
ClinGen ExAC gnomAD |
|
rs913298651 CA117213735 |
106 | Y>C | No |
ClinGen Ensembl |
|
rs368064778 CA117213728 |
109 | G>A | No |
ClinGen Ensembl |
|
rs747608675 CA3248559 |
114 | D>E | No |
ClinGen ExAC gnomAD |
|
rs747608675 CA3248560 |
114 | D>E | No |
ClinGen ExAC gnomAD |
|
rs1427249658 CA359577592 |
115 | Y>C | No |
ClinGen gnomAD |
|
rs773952820 CA3248558 |
119 | N>S | No |
ClinGen ExAC gnomAD |
|
rs1195866028 CA359577049 |
123 | D>G | No |
ClinGen TOPMed gnomAD |
|
rs1263050834 CA359577012 |
128 | R>Q | No |
ClinGen gnomAD |
|
CA117211768 rs865929015 |
128 | R>W | No |
ClinGen gnomAD |
|
CA359577007 rs1382671155 |
129 | R>C | No |
ClinGen gnomAD |
|
rs375372236 CA3248514 |
129 | R>H | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA3248511 rs768829085 |
132 | Q>R | No |
ClinGen ExAC gnomAD |
|
CA117211744 rs975410782 |
135 | L>V | No |
ClinGen gnomAD |
|
rs966217070 CA117211743 |
139 | D>G | No |
ClinGen TOPMed |
|
rs966217070 CA359576942 |
139 | D>V | No |
ClinGen TOPMed |
|
CA117211726 rs866433113 |
160 | A>S | No |
ClinGen Ensembl |
|
rs1339790406 CA359576787 |
161 | H>Y | No |
ClinGen gnomAD |
|
rs1388343363 CA359576774 |
162 | M>I | No |
ClinGen gnomAD |
|
CA359576778 rs1296211909 |
162 | M>T | No |
ClinGen TOPMed gnomAD |
|
CA117211714 rs75538611 |
162 | M>V | No |
ClinGen Ensembl |
|
CA117211702 rs1004603226 |
169 | F>S | No |
ClinGen Ensembl |
|
rs1472964330 CA359576404 |
174 | M>V | No |
ClinGen gnomAD |
|
CA117210170 rs202230529 |
177 | D>H | No |
ClinGen Ensembl |
|
CA3248492 rs780459093 |
180 | F>L | No |
ClinGen ExAC TOPMed gnomAD |
|
rs918424548 CA117210146 |
189 | N>S | No |
ClinGen Ensembl |
|
CA117210138 rs1046709838 |
195 | V>I | No |
ClinGen TOPMed gnomAD |
|
CA3248461 rs753368761 |
208 | I>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA359575526 rs1230232491 |
208 | I>T | No |
ClinGen gnomAD |
|
CA117209063 rs972443048 |
216 | Y>C | No |
ClinGen Ensembl |
|
rs1299322811 CA359575424 |
223 | L>F | No |
ClinGen gnomAD |
|
CA3248456 rs763399194 |
224 | P>R | No |
ClinGen ExAC gnomAD |
|
rs765521994 CA359575385 |
228 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
rs765521994 CA3248454 |
228 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1287731089 CA359575380 |
229 | H>R | No |
ClinGen TOPMed |
|
rs373338557 CA3248453 |
232 | T>A | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA359575362 rs1405608420 |
232 | T>N | No |
ClinGen TOPMed gnomAD |
|
rs373338557 CA359575363 |
232 | T>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA359575361 rs1405608420 |
232 | T>S | No |
ClinGen TOPMed gnomAD |
|
CA117208998 rs999862425 |
233 | L>P | No |
ClinGen TOPMed |
|
rs966382240 CA117208993 |
238 | C>R | No |
ClinGen TOPMed gnomAD |
|
rs1478486576 CA359575300 |
241 | I>F | No |
ClinGen gnomAD |
|
rs1268985916 CA359575293 |
242 | F>V | No |
ClinGen TOPMed |
|
CA3248450 rs747116005 |
243 | Y>C | No |
ClinGen ExAC TOPMed gnomAD |
|
rs770875277 CA3248451 |
243 | Y>H | No |
ClinGen ExAC gnomAD |
|
COSM4159873 COSM4159872 rs1248259974 CA359575234 |
250 | P>H | thyroid [Cosmic] | No |
ClinGen cosmic curated TOPMed gnomAD |
rs1248259974 CA359575233 |
250 | P>L | No |
ClinGen TOPMed gnomAD |
|
CA3248449 rs773074075 |
252 | V>M | No |
ClinGen ExAC gnomAD |
|
CA3248448 rs772054123 |
259 | M>T | No |
ClinGen ExAC gnomAD |
|
CA3248447 rs747908382 |
261 | Q>H | No |
ClinGen ExAC gnomAD |
|
CA3248446 rs778730540 |
264 | P>A | No |
ClinGen ExAC gnomAD |
|
CA117208964 rs959082384 |
265 | M>L | No |
ClinGen Ensembl |
|
CA359575099 rs1360419421 |
270 | I>T | No |
ClinGen gnomAD |
|
rs1214485166 CA359575102 |
270 | I>V | No |
ClinGen gnomAD |
|
rs550046547 CA117208962 |
271 | K>R | No |
ClinGen 1000Genomes gnomAD |
|
CA3248444 rs748853620 |
272 | D>G | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1323447715 CA359575078 |
273 | I>T | No |
ClinGen gnomAD |
|
rs1474740549 CA359575073 |
274 | R>K | No |
ClinGen TOPMed |
|
CA3248425 rs774304395 |
276 | H>R | No |
ClinGen ExAC gnomAD |
|
CA359574147 rs1251461243 |
279 | F>L | No |
ClinGen gnomAD |
|
rs1176712168 CA359574128 |
281 | Q>R | No |
ClinGen gnomAD |
|
rs1479685526 CA359574115 |
283 | L>I | No |
ClinGen gnomAD |
|
rs1561166883 CA359574108 |
284 | P>S | No |
ClinGen Ensembl |
|
CA3248421 rs769558593 |
287 | L>V | No |
ClinGen ExAC gnomAD |
|
rs780896222 CA3248419 |
289 | P>L | No |
ClinGen ExAC gnomAD |
|
CA359574069 rs1354003048 |
290 | E>Q | No |
ClinGen gnomAD |
|
rs535217762 CA3248418 |
291 | D>A | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs542464918 CA3248416 |
294 | Y>C | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs1414109649 CA359574003 |
299 | I>T | No |
ClinGen TOPMed gnomAD |
|
CA3248414 rs754284731 |
301 | D>H | No |
ClinGen ExAC gnomAD |
|
CA117207623 rs754284731 |
301 | D>N | No |
ClinGen ExAC gnomAD |
|
rs766503818 CA3248413 |
303 | A>V | No |
ClinGen ExAC gnomAD |
|
rs760937861 CA3248412 |
308 | C>R | No |
ClinGen ExAC gnomAD |
|
CA359573938 rs1455034302 |
308 | C>W | No |
ClinGen TOPMed |
|
CA359573932 rs1158613441 |
309 | E>G | No |
ClinGen gnomAD |
|
rs958041636 CA117207597 |
314 | S>A | No |
ClinGen TOPMed |
|
rs958041636 CA359573896 |
314 | S>P | No |
ClinGen TOPMed |
|
CA117207589 rs772627284 |
318 | V>I | No |
ClinGen gnomAD |
|
rs1255970170 CA359573862 |
319 | L>V | No |
ClinGen gnomAD |
|
CA359573699 rs1579711633 |
338 | I>M | No |
ClinGen Ensembl |
|
CA359573616 rs1259851932 |
345 | M>T | No |
ClinGen gnomAD |
|
CA3248407 rs768701727 |
351 | F>I | No |
ClinGen ExAC gnomAD |
|
rs775398537 CA3248405 |
352 | Y>C | No |
ClinGen ExAC gnomAD |
|
rs769305521 CA3248404 |
354 | A>V | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1400427220 CA359573434 |
355 | T>A | No |
ClinGen gnomAD |
|
rs371800275 CA3248402 |
356 | S>N | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA3248401 rs770495904 |
357 | P>A | No |
ClinGen ExAC gnomAD |
|
CA359573353 rs1351762701 |
359 | D>E | No |
ClinGen gnomAD |
|
rs1030169288 CA117207513 |
360 | S>C | No |
ClinGen TOPMed gnomAD |
|
rs1030169288 CA359573332 |
360 | S>Y | No |
ClinGen TOPMed gnomAD |
|
rs779274909 CA3248399 |
361 | F>S | No |
ClinGen ExAC gnomAD |
|
rs1416393253 CA359573292 |
362 | L>R | No |
ClinGen gnomAD |
|
CA359573301 rs1344489723 |
362 | L>V | No |
ClinGen TOPMed gnomAD |
|
CA359573260 rs1196469993 |
364 | D>G | No |
ClinGen gnomAD |
|
CA359573171 rs1261488694 |
368 | T>I | No |
ClinGen gnomAD |
|
CA359573168 rs1489277086 |
369 | R>Q | No |
ClinGen gnomAD |
|
rs570874680 CA3248397 |
369 | R>W | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA359573162 rs1273370147 |
370 | P>L | No |
ClinGen TOPMed gnomAD |
|
CA359573138 rs1331990523 |
373 | E>D | No |
ClinGen gnomAD |
|
rs1212575008 CA359573144 |
373 | E>Q | No |
ClinGen gnomAD |
|
CA117207500 rs369305280 |
374 | R>K | No |
ClinGen ESP TOPMed |
|
rs780419077 CA3248396 |
375 | V>G | No |
ClinGen ExAC gnomAD |
|
CA359573093 rs1561166384 |
381 | E>* | No |
ClinGen Ensembl |
|
rs995813654 CA117207471 |
382 | T>A | No |
ClinGen Ensembl |
|
rs1224388471 CA359573073 |
384 | R>G | No |
ClinGen TOPMed |
|
CA117207459 COSM1437557 COSM1437558 rs866107019 |
386 | R>C | large_intestine [Cosmic] | No |
ClinGen cosmic curated TOPMed |
CA359573056 COSM1437555 COSM1437556 rs1175516950 |
386 | R>H | large_intestine [Cosmic] | No |
ClinGen cosmic curated gnomAD |
CA3248393 rs558686996 |
387 | H>Q | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs201118044 RCV000943351 CA3248394 |
387 | H>R | No |
ClinGen ClinVar ESP ExAC TOPMed dbSNP gnomAD |
|
CA359573045 rs1187435229 |
388 | T>S | No |
ClinGen TOPMed |
|
CA3248391 rs141253847 |
391 | E>K | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
CA3248390 rs141253847 |
391 | E>Q | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs1395301525 CA359572957 |
400 | Q>H | No |
ClinGen TOPMed |
|
CA117207429 rs1055420381 |
401 | G>C | No |
ClinGen TOPMed gnomAD |
|
CA359572956 rs1055420381 |
401 | G>S | No |
ClinGen TOPMed gnomAD |
|
rs1321482842 CA359572952 |
401 | G>V | No |
ClinGen TOPMed |
|
CA359572951 rs1349178291 |
402 | V>I | No |
ClinGen TOPMed |
|
rs1049367137 CA117207425 |
405 | A>V | No |
ClinGen Ensembl |
|
rs1372969872 CA359572866 |
413 | S>R | No |
ClinGen gnomAD |
|
CA3248386 rs747861746 |
416 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
rs930517925 CA117207393 |
418 | N>K | No |
ClinGen TOPMed |
|
CA3248383 rs770763740 |
422 | A>T | No |
ClinGen ExAC gnomAD |
|
CA3248381 rs772818846 |
425 | C>R | No |
ClinGen ExAC TOPMed gnomAD |
|
rs749762932 CA3248379 |
426 | R>K | No |
ClinGen ExAC gnomAD |
|
CA359572764 rs1207503865 |
428 | I>M | No |
ClinGen TOPMed |
|
CA359572769 rs1235199897 |
428 | I>V | No |
ClinGen gnomAD |
|
CA359572757 rs1304524923 |
429 | K>N | No |
ClinGen gnomAD |
|
RCV000892214 CA3248378 rs146544425 |
429 | K>R | No |
ClinGen ClinVar 1000Genomes ESP ExAC TOPMed dbSNP gnomAD |
|
rs372372938 CA3248377 |
430 | Q>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA359572725 rs1391991049 |
434 | E>K | No |
ClinGen gnomAD |
|
CA117207184 rs1052662585 |
440 | P>L | No |
ClinGen TOPMed |
|
rs1389372463 CA359572668 |
440 | P>S | No |
ClinGen gnomAD |
|
rs1433191043 CA359572640 COSM1068155 |
444 | R>C | endometrium [Cosmic] | No |
ClinGen cosmic curated gnomAD |
rs747211627 CA3248354 |
444 | R>H | No |
ClinGen ExAC gnomAD |
|
rs747211627 CA3248355 |
444 | R>L | No |
ClinGen ExAC gnomAD |
|
rs747211627 CA359572639 |
444 | R>P | No |
ClinGen ExAC gnomAD |
|
CA359572631 rs1444272285 |
446 | R>* | No |
ClinGen TOPMed |
|
CA3248353 rs370544157 |
446 | R>Q | No |
ClinGen ESP ExAC gnomAD |
|
rs1361573994 CA359572609 |
449 | N>S | No |
ClinGen gnomAD |
|
rs778987497 CA3248352 |
450 | P>A | No |
ClinGen ExAC TOPMed gnomAD |
|
rs778987497 CA3248351 |
450 | P>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3248350 rs778987497 |
450 | P>T | No |
ClinGen ExAC TOPMed gnomAD |
|
rs753662810 CA3248348 |
452 | T>I | No |
ClinGen ExAC gnomAD |
|
CA359572590 rs1208526937 |
453 | S>G | No |
ClinGen gnomAD |
|
CA359572573 rs1357593691 |
455 | Y>C | No |
ClinGen TOPMed gnomAD |
|
CA117207107 rs979993957 |
457 | K>N | No |
ClinGen TOPMed gnomAD |
|
CA359572562 rs1489129414 |
457 | K>Q | No |
ClinGen gnomAD |
|
rs766237840 CA3248347 |
457 | K>R | No |
ClinGen ExAC gnomAD |
|
rs1193269441 CA359572539 |
460 | L>V | No |
ClinGen TOPMed |
|
CA359572533 rs1561165666 |
461 | Q>* | No |
ClinGen Ensembl |
|
CA359572519 rs1350147490 |
463 | Y>H | No |
ClinGen gnomAD |
|
CA359572495 rs1178543256 |
466 | D>A | No |
ClinGen TOPMed gnomAD |
|
CA359572474 rs1433777150 |
469 | T>A | No |
ClinGen gnomAD |
|
rs1235170260 CA359572466 |
470 | Y>S | No |
ClinGen gnomAD |
|
rs767134351 CA3248344 |
474 | F>I | No |
ClinGen ExAC gnomAD |
|
CA117207090 rs879302536 |
475 | R>C | No |
ClinGen gnomAD |
|
CA3248343 rs761385811 |
475 | R>H | No |
ClinGen ExAC TOPMed gnomAD |
|
CA359572434 rs761385811 |
475 | R>P | No |
ClinGen ExAC TOPMed gnomAD |
|
rs773894144 CA3248342 |
477 | I>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3248341 rs770267711 |
478 | D>V | No |
ClinGen ExAC gnomAD |
|
CA3248318 rs371307629 |
484 | A>G | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA3248319 rs371307629 |
484 | A>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs748330955 CA3248317 |
486 | S>L | No |
ClinGen ExAC gnomAD |
|
CA3248316 rs774720365 |
489 | A>P | No |
ClinGen ExAC gnomAD |
|
CA3248314 rs749439577 |
490 | T>A | No |
ClinGen ExAC TOPMed gnomAD |
|
CA3248313 rs780136282 |
491 | P>S | No |
ClinGen ExAC gnomAD |
|
CA3248312 rs756048705 |
493 | R>T | No |
ClinGen ExAC TOPMed gnomAD |
|
rs377722592 CA3248311 |
494 | S>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1271858075 CA359572220 |
499 | N>S | No |
ClinGen gnomAD |
|
rs373496949 CA3248309 |
500 | Y>C | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs369722345 CA117206228 |
501 | R>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs369722345 CA3248308 |
501 | R>P | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs369722345 CA117206232 |
501 | R>Q | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA359572179 rs1369698439 |
502 | S>C | No |
ClinGen gnomAD |
|
rs1249689552 CA359572117 |
506 | S>R | No |
ClinGen TOPMed |
|
CA359572089 rs1230030619 |
508 | S>L | No |
ClinGen gnomAD |
|
CA3248306 rs373650446 |
511 | E>K | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA3248305 rs200834318 |
513 | Q>R | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA117206190 rs924546469 |
517 | S>A | No |
ClinGen Ensembl |
|
CA359571868 rs1198216596 |
521 | L>F | No |
ClinGen TOPMed |
|
rs1408060601 CA359571845 |
522 | T>I | No |
ClinGen gnomAD |
|
CA359571782 rs1314323666 |
526 | T>N | No |
ClinGen gnomAD |
|
CA3248301 rs759783859 |
528 | L>F | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1394656931 CA359571714 |
530 | S>F | No |
ClinGen gnomAD |
|
rs767733105 CA3248300 |
531 | S>F | No |
ClinGen ExAC gnomAD |
|
rs79215941 CA117206168 |
533 | V>A | No |
ClinGen Ensembl |
|
CA359571662 rs1461908786 |
534 | D>V | No |
ClinGen TOPMed |
|
CA117206163 rs368455500 |
537 | P>L | No |
ClinGen TOPMed gnomAD |
|
CA359571602 rs1436516797 |
538 | R>K | No |
ClinGen gnomAD |
|
rs537660683 CA3248297 |
539 | P>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs537660683 CA3248298 |
539 | P>T | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA359571536 rs1346729889 |
542 | H>N | No |
ClinGen gnomAD |
|
CA3248296 rs749349784 |
542 | H>R | No |
ClinGen ExAC gnomAD |
|
rs769941751 CA3248294 |
544 | I>T | No |
ClinGen ExAC gnomAD |
|
CA359571487 rs1341286749 |
544 | I>V | No |
ClinGen TOPMed |
|
CA3248293 rs745757450 |
545 | E>G | No |
ClinGen ExAC gnomAD |
|
rs774750291 CA3248291 |
549 | M>I | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1561164246 CA359571396 |
549 | M>K | No |
ClinGen Ensembl |
|
CA359571349 rs1377155034 |
551 | A>V | No |
ClinGen gnomAD |
|
CA3248290 rs756983376 |
555 | K>N | No |
ClinGen ExAC gnomAD |
|
rs1293501358 CA359570014 |
557 | L>V | No |
ClinGen TOPMed |
No associated diseases with Q13131
6 regional properties for Q13131
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 27 - 279 | IPR000719 |
active_site | Serine/threonine-protein kinase, active site | 146 - 158 | IPR008271 |
binding_site | Protein kinase, ATP binding site | 33 - 56 | IPR017441 |
domain | PRKAA1, UBA-like autoinhibitory domain | 296 - 360 | IPR028797 |
domain | AMPK, C-terminal adenylate sensor domain | 406 - 480 | IPR032270 |
domain | 5'-AMP-activated protein kinase alpha 1 catalytic subunit, C-terminal | 404 - 557 | IPR039137 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.11.1 | Protein-serine/threonine kinases |
Subcellular Localization |
|
|
PANTHER Family | PTHR24346 | MAP/MICROTUBULE AFFINITY-REGULATING KINASE |
PANTHER Subfamily | PTHR24346:SF82 | SERINE_THREONINE-PROTEIN KINASE MARK-A-RELATED |
PANTHER Protein Class |
non-receptor serine/threonine protein kinase
protein modifying enzyme |
|
PANTHER Pathway Category |
p53 pathway by glucose deprivation AMPK |
10 GO annotations of cellular component
Name | Definition |
---|---|
apical plasma membrane | The region of the plasma membrane located at the apical end of the cell. |
axon | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
nuclear speck | A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleotide-activated protein kinase complex | A protein complex that possesses nucleotide-dependent protein kinase activity. The nucleotide can be AMP (in S. pombe and human) or ADP (in S. cerevisiae). |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
16 GO annotations of molecular function
Name | Definition |
---|---|
[acetyl-CoA carboxylase] kinase activity | Catalysis of the reaction: ATP |
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity | +Catalysis of the reaction: [3-hydroxy-3-methylglutaryl-CoA reductase (NADPH)] + ATP = [3-hydroxy-3-methylglutaryl-CoA reductase (NADPH)] phosphate + ADP. |
AMP-activated protein kinase activity | Catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein. This reaction requires the presence of AMP. |
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
cAMP-dependent protein kinase activity | cAMP-dependent catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein. |
chromatin binding | Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. |
histone serine kinase activity | Catalysis of the transfer of a phosphate group to a serine residue of a histone. |
metal ion binding | Binding to a metal ion. |
protein C-terminus binding | Binding to a protein C-terminus, the end of a peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue. |
protein kinase activity | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
protein serine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate. |
protein serine/threonine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
protein serine/threonine/tyrosine kinase activity | Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate. |
protein-containing complex binding | Binding to a macromolecular complex. |
tau protein binding | Binding to tau protein. tau is a microtubule-associated protein, implicated in Alzheimer's disease, Down Syndrome and ALS. |
tau-protein kinase activity | Catalysis of the reaction: ATP + tau-protein = ADP + O-phospho-tau-protein. |
63 GO annotations of biological process
Name | Definition |
---|---|
autophagy | The cellular catabolic process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation. |
bile acid and bile salt transport | The directed movement of bile acid and bile salts into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
bile acid signaling pathway | The series of molecular signals initiated by bile acid binding to its receptor, and ending with the regulation of a downstream cellular process, e.g. transcription. |
CAMKK-AMPK signaling cascade | The series of molecular signals in which calmodulin-dependent protein kinase activity enabled by a CAMKK directly activates an AMPK. The cascade begins with calmodulin binding calcium which in turn binds CAMKK enabling its calmodulin-dependent protein kinase activity. The cascade ends with AMP-activated protein kinase activity. |
cellular response to calcium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
cellular response to ethanol | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
cellular response to glucose starvation | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of glucose. |
cellular response to glucose stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus. |
cellular response to hydrogen peroxide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
cellular response to hypoxia | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
cellular response to nutrient levels | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
cellular response to organonitrogen compound | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organonitrogen stimulus. An organonitrogen compound is formally a compound containing at least one carbon-nitrogen bond. |
cellular response to oxidative stress | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
cellular response to prostaglandin E stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus. |
cellular response to xenobiotic stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organism exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
cholesterol biosynthetic process | The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. |
chromatin organization | The assembly or remodeling of chromatin composed of DNA complexed with histones, other associated proteins, and sometimes RNA. |
cold acclimation | Any process that increases freezing tolerance of an organism in response to low, nonfreezing temperatures. |
energy homeostasis | Any process involved in the balance between food intake (energy input) and energy expenditure. |
fatty acid biosynthetic process | The chemical reactions and pathways resulting in the formation of a fatty acid, any of the aliphatic monocarboxylic acids that can be liberated by hydrolysis from naturally occurring fats and oils. Fatty acids are predominantly straight-chain acids of 4 to 24 carbon atoms, which may be saturated or unsaturated; branched fatty acids and hydroxy fatty acids also occur, and very long chain acids of over 30 carbons are found in waxes. |
fatty acid homeostasis | Any process involved in the maintenance of an internal steady state of fatty acid within an organism or cell. |
fatty acid oxidation | The removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen. |
glucose homeostasis | Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
glucose metabolic process | The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
lipid biosynthetic process | The chemical reactions and pathways resulting in the formation of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. |
motor behavior | The specific neuromuscular movement of a single organism in response to external or internal stimuli. |
negative regulation of apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
negative regulation of gene expression | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
negative regulation of glucosylceramide biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glucosylceramide. |
negative regulation of hepatocyte apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of hepatocyte apoptotic process. |
negative regulation of insulin receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling. |
negative regulation of lipid catabolic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of lipids. |
negative regulation of TOR signaling | Any process that stops, prevents, or reduces the frequency, rate or extent of TOR signaling. |
negative regulation of tubulin deacetylation | Any process that stops, prevents or reduces the frequency, rate or extent of tubulin deacetylation. |
neuron cellular homeostasis | The cellular homeostatic process that preserves a neuron in a stable, differentiated functional and structural state. |
positive regulation of autophagy | Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
positive regulation of cholesterol biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of glycolytic process | Any process that activates or increases the frequency, rate or extent of glycolysis. |
positive regulation of mitochondrial transcription | Any process that activates or increases the frequency, rate or extent of transcription occuring in the mitochondrion. |
positive regulation of peptidyl-lysine acetylation | Any process that activates or increases the frequency, rate or extent of peptidyl-lysine acetylation. |
positive regulation of protein localization | Any process that activates or increases the frequency, rate or extent of a protein localization. |
positive regulation of protein targeting to mitochondrion | Any process that activates or increases the frequency, rate or extent of protein targeting to mitochondrion. |
positive regulation of skeletal muscle tissue development | Any process that activates, maintains or increases the rate of skeletal muscle tissue development. |
protein phosphorylation | The process of introducing a phosphate group on to a protein. |
regulation of bile acid secretion | Any process that modulates the frequency, rate or extent of the controlled release of bile acid from a cell or a tissue. |
regulation of circadian rhythm | Any process that modulates the frequency, rate or extent of a circadian rhythm. A circadian rhythm is a biological process in an organism that recurs with a regularity of approximately 24 hours. |
regulation of microtubule cytoskeleton organization | Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins. |
regulation of peptidyl-serine phosphorylation | Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
regulation of stress granule assembly | Any process that modulates the rate, frequency or extent of stress granule assembly, the aggregation, arrangement and bonding together of proteins and RNA molecules to form a stress granule. |
regulation of vesicle-mediated transport | Any process that modulates the rate, frequency, or extent of vesicle-mediated transport, the directed movement of substances, either within a vesicle or in the vesicle membrane, into, out of or within a cell. |
response to 17alpha-ethynylestradiol | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 17alpha-ethynylestradiol stimulus. |
response to activity | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus. |
response to caffeine | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a caffeine stimulus. Caffeine is an alkaloid found in numerous plant species, where it acts as a natural pesticide that paralyzes and kills certain insects feeding upon them. |
response to camptothecin | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a camptothecin stimulus. |
response to gamma radiation | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum. |
response to hypoxia | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
response to UV | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. |
rhythmic process | Any process pertinent to the generation and maintenance of rhythms in the physiology of an organism. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
Wnt signaling pathway | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state. |
72 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q02066 | Abscisic acid-inducible protein kinase | Triticum aestivum (Wheat) | PR | |
P06782 | SNF1 | Carbon catabolite-derepressing protein kinase | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) | EV |
Q5GLH2 | TRIB2 | Tribbles homolog 2 | Bos taurus (Bovine) | SS |
Q0VCE3 | TRIB3 | Tribbles homolog 3 | Bos taurus (Bovine) | SS |
Q3SZW1 | TSSK1B | Testis-specific serine/threonine-protein kinase 1 | Bos taurus (Bovine) | PR |
Q92519 | TRIB2 | Tribbles homolog 2 | Homo sapiens (Human) | SS |
Q96RU7 | TRIB3 | Tribbles homolog 3 | Homo sapiens (Human) | PR |
Q96RU8 | TRIB1 | Tribbles homolog 1 | Homo sapiens (Human) | EV |
Q15831 | STK11 | Serine/threonine-protein kinase STK11 | Homo sapiens (Human) | PR |
Q96RG2 | PASK | PAS domain-containing serine/threonine-protein kinase | Homo sapiens (Human) | EV |
O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | Homo sapiens (Human) | EV |
Q8IWQ3 | BRSK2 | Serine/threonine-protein kinase BRSK2 | Homo sapiens (Human) | PR |
Q8TDC3 | BRSK1 | Serine/threonine-protein kinase BRSK1 | Homo sapiens (Human) | SS |
Q14680 | MELK | Maternal embryonic leucine zipper kinase | Homo sapiens (Human) | EV |
P57059 | SIK1 | Serine/threonine-protein kinase SIK1 | Homo sapiens (Human) | PR |
Q9NRH2 | SNRK | SNF-related serine/threonine-protein kinase | Homo sapiens (Human) | SS |
Q9BXA7 | TSSK1B | Testis-specific serine/threonine-protein kinase 1 | Homo sapiens (Human) | PR |
O60285 | NUAK1 | NUAK family SNF1-like kinase 1 | Homo sapiens (Human) | PR |
P54646 | PRKAA2 | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Homo sapiens (Human) | EV |
Q8K4K3 | Trib2 | Tribbles homolog 2 | Mus musculus (Mouse) | SS |
Q61241 | Tssk1b | Testis-specific serine/threonine-protein kinase 1 | Mus musculus (Mouse) | PR |
Q8K4K2 | Trib3 | Tribbles homolog 3 | Mus musculus (Mouse) | SS |
O54863 | Tssk2 | Testis-specific serine/threonine-protein kinase 2 | Mus musculus (Mouse) | PR |
Q8K4K4 | Trib1 | Tribbles homolog 1 | Mus musculus (Mouse) | SS |
Q61846 | Melk | Maternal embryonic leucine zipper kinase | Mus musculus (Mouse) | PR |
Q8BRK8 | Prkaa2 | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Mus musculus (Mouse) | SS |
Q5EG47 | Prkaa1 | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Mus musculus (Mouse) | SS |
Q28948 | PRKAA2 | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Sus scrofa (Pig) | SS |
Q09136 | PRKAA1 | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Sus scrofa (Pig) | SS |
Q9WTQ6 | Trib3 | Tribbles homolog 3 | Rattus norvegicus (Rat) | SS |
Q09137 | Prkaa2 | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Rattus norvegicus (Rat) | EV |
P54645 | Prkaa1 | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Rattus norvegicus (Rat) | EV |
Q5QNM6 | CIPK13 | Putative CBL-interacting protein kinase 13 | Oryza sativa subsp japonica (Rice) | PR |
Q5JLQ9 | CIPK30 | CBL-interacting protein kinase 30 | Oryza sativa subsp japonica (Rice) | PR |
Q5N942 | SAPK4 | Serine/threonine-protein kinase SAPK4 | Oryza sativa subsp japonica (Rice) | PR |
Q852Q0 | OSK3 | Serine/threonine protein kinase OSK3 | Oryza sativa subsp. japonica (Rice) | SS |
Q75LR7 | SAPK1 | Serine/threonine-protein kinase SAPK1 | Oryza sativa subsp japonica (Rice) | PR |
Q75H77 | SAPK10 | Serine/threonine-protein kinase SAPK10 | Oryza sativa subsp japonica (Rice) | PR |
Q7Y0B9 | SAPK8 | Serine/threonine-protein kinase SAPK8 | Oryza sativa subsp japonica (Rice) | PR |
Q7XQP4 | SAPK7 | Serine/threonine-protein kinase SAPK7 | Oryza sativa subsp japonica (Rice) | PR |
Q0D4J7 | SAPK2 | Serine/threonine-protein kinase SAPK2 | Oryza sativa subsp japonica (Rice) | PR |
Q6ERS4 | CIPK16 | CBL-interacting protein kinase 16 | Oryza sativa subsp japonica (Rice) | PR |
P0C5D6 | SAPK3 | Serine/threonine-protein kinase SAPK3 | Oryza sativa subsp japonica (Rice) | PR |
Q75V57 | SAPK9 | Serine/threonine-protein kinase SAPK9 | Oryza sativa subsp japonica (Rice) | PR |
Q8LIG4 | CIPK3 | CBL-interacting protein kinase 3 | Oryza sativa subsp japonica (Rice) | PR |
Q852Q1 | OSK4 | Serine/threonine protein kinase OSK4 | Oryza sativa subsp. japonica (Rice) | SS |
Q852Q2 | OSK1 | Serine/threonine protein kinase OSK1 | Oryza sativa subsp. japonica (Rice) | SS |
Q6ZLP5 | CIPK23 | CBL-interacting protein kinase 23 | Oryza sativa subsp japonica (Rice) | PR |
Q2RAX3 | CIPK33 | CBL-interacting protein kinase 33 | Oryza sativa subsp japonica (Rice) | PR |
Q2QY53 | CIPK32 | CBL-interacting protein kinase 32 | Oryza sativa subsp japonica (Rice) | PR |
Q21017 | kin-29 | Serine/threonine-protein kinase kin-29 | Caenorhabditis elegans | SS |
Q95ZQ4 | aak-2 | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Caenorhabditis elegans | SS |
P45894 | aak-1 | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Caenorhabditis elegans | SS |
P43291 | SRK2A | Serine/threonine-protein kinase SRK2A | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9C958 | SRK2B | Serine/threonine-protein kinase SRK2B | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9M9E9 | SRK2C | Serine/threonine-protein kinase SRK2C | Arabidopsis thaliana (Mouse-ear cress) | PR |
O64812 | SRK2J | Serine/threonine-protein kinase SRK2J | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q2V452 | CIPK3 | CBL-interacting serine/threonine-protein kinase 3 | Arabidopsis thaliana (Mouse-ear cress) | SS |
O22971 | CIPK13 | CBL-interacting serine/threonine-protein kinase 13 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q39192 | SRK2D | Serine/threonine-protein kinase SRK2D | Arabidopsis thaliana (Mouse-ear cress) | PR |
O65554 | CIPK6 | CBL-interacting serine/threonine-protein kinase 6 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q940H6 | SRK2E | Serine/threonine-protein kinase SRK2E | Arabidopsis thaliana (Mouse-ear cress) | PR |
P43292 | SRK2G | Serine/threonine-protein kinase SRK2G | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9FJ54 | CIPK20 | CBL-interacting serine/threonine-protein kinase 20 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9FFP9 | SRK2H | Serine/threonine-protein kinase SRK2H | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q39193 | SRK2I | Serine/threonine-protein kinase SRK2I | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q94CG0 | CIPK21 | CBL-interacting serine/threonine-protein kinase 21 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q93VD3 | CIPK23 | CBL-interacting serine/threonine-protein kinase 23 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9LDI3 | CIPK24 | CBL-interacting serine/threonine-protein kinase 24 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q9FLZ3 | KIN12 | SNF1-related protein kinase catalytic subunit alpha KIN12 | Arabidopsis thaliana (Mouse-ear cress) | SS |
P92958 | KIN11 | SNF1-related protein kinase catalytic subunit alpha KIN11 | Arabidopsis thaliana (Mouse-ear cress) | PR |
Q38997 | KIN10 | SNF1-related protein kinase catalytic subunit alpha KIN10 | Arabidopsis thaliana (Mouse-ear cress) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MRRLSSWRKM | ATAEKQKHDG | RVKIGHYILG | DTLGVGTFGK | VKVGKHELTG | HKVAVKILNR |
70 | 80 | 90 | 100 | 110 | 120 |
QKIRSLDVVG | KIRREIQNLK | LFRHPHIIKL | YQVISTPSDI | FMVMEYVSGG | ELFDYICKNG |
130 | 140 | 150 | 160 | 170 | 180 |
RLDEKESRRL | FQQILSGVDY | CHRHMVVHRD | LKPENVLLDA | HMNAKIADFG | LSNMMSDGEF |
190 | 200 | 210 | 220 | 230 | 240 |
LRTSCGSPNY | AAPEVISGRL | YAGPEVDIWS | SGVILYALLC | GTLPFDDDHV | PTLFKKICDG |
250 | 260 | 270 | 280 | 290 | 300 |
IFYTPQYLNP | SVISLLKHML | QVDPMKRATI | KDIREHEWFK | QDLPKYLFPE | DPSYSSTMID |
310 | 320 | 330 | 340 | 350 | 360 |
DEALKEVCEK | FECSEEEVLS | CLYNRNHQDP | LAVAYHLIID | NRRIMNEAKD | FYLATSPPDS |
370 | 380 | 390 | 400 | 410 | 420 |
FLDDHHLTRP | HPERVPFLVA | ETPRARHTLD | ELNPQKSKHQ | GVRKAKWHLG | IRSQSRPNDI |
430 | 440 | 450 | 460 | 470 | 480 |
MAEVCRAIKQ | LDYEWKVVNP | YYLRVRRKNP | VTSTYSKMSL | QLYQVDSRTY | LLDFRSIDDE |
490 | 500 | 510 | 520 | 530 | 540 |
ITEAKSGTAT | PQRSGSVSNY | RSCQRSDSDA | EAQGKSSEVS | LTSSVTSLDS | SPVDLTPRPG |
550 | |||||
SHTIEFFEMC | ANLIKILAQ |